Biernacki et al. Real-world data on the efficacy and long-term use of fingolimod in Hungary

Background: Fingolimod was approved and reimbursed by the healthcare provider in Hungary for the treatment of highly active relapsing-remitting multiple sclerosis (RRMS) in 2012. The present study aimed to assess the effectiveness, safety profile, and persistence to fingolimod in a real-life setting...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Tamás, Biernacki, Sandi, Dániel, Füvesi, Judit, Fricska-Nagy, Zsanett, Tamás Kincses, Zsigmond, Acs, Peter, Rozsa, Csilla, Dobos, Enikő, Cseh, Botond, Horvath, Laszlo, Nagy, Zsuzsanna, Csanyi, Attila, Kovacs, Krisztina, Csépány, Tünde, Vécsei, László, Bencsik, Krisztina
Format:	Dataset
Sprache:	eng
Schlagworte:	Neuroscience
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!